Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4326
PUT
TKO Group
TKO
$14.1B
| $825K | ﹤0.01% |
4,100
-7,900
| -66% | -$1.54M |
2023 Q4
10 quarters
|
|
4327
Biote Corp
BTMD
$35.3M
| $824K | ﹤0.01% |
+436,088
| New | +$898K |
2026 Q2
0 quarters
|
|
4328
Runway Growth Finance
RWAY
$275M
| $816K | ﹤0.01% |
+145,448
| New | +$921K |
2026 Q2
0 quarters
|
|
4329
Cars.com
CARS
$683M
| $816K | ﹤0.01% |
74,556
-574,350
| -89% | -$5.84M |
2022 Q1
17 quarters
|
|
4330
CALL
Revolution Medicines Inc Warrant
RVMDW
$93.8M
| $814K | ﹤0.01% |
86,828
| – | – |
2023 Q4
10 quarters
|
|
4331
RBB Bancorp
RBB
$444M
| $812K | ﹤0.01% |
29,632
+11,371
| +62% | +$273K |
2025 Q1
5 quarters
|
|
4332
Niu Technologies
NIU
$140M
| $812K | ﹤0.01% |
404,149
+327,380
| +426% | +$867K |
2023 Q3
11 quarters
|
|
4333
Zura Bio
ZURA
$387M
| $812K | ﹤0.01% |
137,639
-1,370,424
| -91% | -$6.53M |
2024 Q3
7 quarters
|
|
4334
Stellus Capital Investment Corp
SCM
$207M
| $812K | ﹤0.01% |
96,424
-20,243
| -17% | -$186K |
2026 Q1
1 quarter
|
|
4335
Meridian
MRBK
$204M
| $810K | ﹤0.01% |
40,428
+16,723
| +71% | +$317K |
2021 Q2
20 quarters
|
|
4336
Essex Property Trust
ESS
$17.5B
| $808K | ﹤0.01% |
2,771
-64,174
| -96% | -$17.3M |
2025 Q3
3 quarters
|
|
4337
Americas Gold and Silver
USAS
$998M
| $807K | ﹤0.01% |
171,005
-248,908
| -59% | -$1.44M |
2023 Q1
13 quarters
|
|
4338
TRX Gold Corp
TRX
$308M
| $807K | ﹤0.01% |
976,662
+721,167
| +282% | +$836K |
2026 Q1
1 quarter
|
|
4339
BNB Standard Corporation Common Stock
BNC
$223M
| $807K | ﹤0.01% |
296,577
-282,985
| -49% | -$773K |
2025 Q3
3 quarters
|
|
4340
BridgeBio Oncology
BBOT
$184M
| $804K | ﹤0.01% |
105,480
-160,474
| -60% | -$1.34M |
2024 Q1
9 quarters
|
|
4341
inTEST
INTT
$158M
| $803K | ﹤0.01% |
44,174
-32,352
| -42% | -$548K |
2026 Q1
1 quarter
|
|
4342
Aimco
AIV
$245M
| $801K | ﹤0.01% |
269,647
-240,607
| -47% | -$922K |
2022 Q3
15 quarters
|
|
4343
CALL
TransDigm Group
TDG
$67.3B
| $799K | ﹤0.01% |
600
+100
| +20% | +$123K |
2026 Q1
1 quarter
|
|
4344
PUT
MACOM Technology Solutions
MTSI
$14.5B
| $799K | ﹤0.01% |
+2,100
| New | +$697K |
2026 Q2
0 quarters
|
|
4345
SOPHiA GENETICS
SOPH
$597M
| $799K | ﹤0.01% |
138,409
+128,267
| +1,265% | +$651K |
2021 Q3
19 quarters
|
|
4346
CALL
Tyra Biosciences
TYRA
$1.48B
| $798K | ﹤0.01% |
25,000
-15,000
| -38% | -$496K |
2026 Q1
1 quarter
|
|
4347
NewtekOne
NEWT
$318M
| $798K | ﹤0.01% |
53,863
-9,008
| -14% | -$119K |
2023 Q4
10 quarters
|
|
4348
ProShares UltraShort S&P500
SDS
$402M
| $796K | ﹤0.01% |
14,000
+6,000
| +75% | +$366K |
2026 Q1
1 quarter
|
|
4349
PUT
Casey's General Stores
CASY
$24.9B
| $795K | ﹤0.01% |
+1,000
| New | +$806K |
2026 Q2
0 quarters
|
|
4350
MSC Income Fund Inc
MSIF
$555M
| $794K | ﹤0.01% |
68,599
-57,480
| -46% | -$703K |
2025 Q3
3 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.